PATENT CLAIM ANALYSIS

Application Number: 15938952
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "491000"]

Abstract:
The present invention provides methods and compositions for treating bladder cancer, including metastatic bladder cancer and non-muscle-invasive bladder cancer, by administering a composition comprising nanoparticles that comprise mTOR inhibitor and optionally an albumin.

Claim (Index 1):
A method of treating bladder cancer in an individual, comprising administering to the individual an effective amount of a composition comprising nanoparticles comprising a limus drug and an albumin.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 90.0
- Lexical Diversity: 1.24138
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14772725', '13073861', '15192077', '12530188', '13782990']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6844167050272265
- 35 USC 102 Novelty (BERT): 0.6293439030679208
- Combined Prediction Score: 0.6789094248312959
- Mean Citation Score: 274.057166
- Max Citation Score: 455.20026
- Similarity Product: 417.5141684138345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test